These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 689797)

  • 1. The relative bioavailability and pharmacokinetics of carbamazepine.
    Richter K; Terhaag B
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):377-9. PubMed ID: 689797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of carbamazepine in the neonate and in the child.
    Rey E; d'Athis P; de Lauture D; Dulac O; Aicardi J; Olive G
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):90-6. PubMed ID: 422308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration.
    Breimer DD; de Boer AG
    Arzneimittelforschung; 1976; 26(3):448-54. PubMed ID: 989344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration behavior of carbamazepine in bile and plasma of man.
    Terhaag B; Richter K; Diettrich H
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):607-9. PubMed ID: 730428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into the relative bioavailability of carbamazepine after single oral administration of three test batches of a carbamazepine-containing sustained release formulation in healthy subjects.
    Schulz HU; Düsing R; Grunwald F; Czaja J; Lührmann B; Frecks HJ
    Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):139-44. PubMed ID: 1572759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carbamazepine: the bioavailability of 4 oral pharmaceutical products].
    Saavedra I; Passalacqua A; Chávez H; Biagini L; Galdames D
    Rev Med Chil; 1990 Oct; 118(10):1123-8. PubMed ID: 2152631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bioavailability of carbamazepine.
    Cotter LM; Smith G; Hooper WD; Tyrer JH; Eadie MJ
    Proc Aust Assoc Neurol; 1975; 12():123-8. PubMed ID: 1215378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of two carbamazepine tablets.
    Glende M; Hüller H; Mai I; Migulla H; Prümke J; Schumann G
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):631-3. PubMed ID: 6668101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palatability and relative bioavailability of an extemporaneous carbamazepine oral suspension.
    Bloomer D; Dupuis LL; MacGregor D; Soldin SJ
    Clin Pharm; 1987 Aug; 6(8):646-9. PubMed ID: 3691011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relative bioavailability and pharmacokinetics of chloral hydrate and its metabolites].
    Zimmermann T; Wehling M; Schulz HU
    Arzneimittelforschung; 1998 Jan; 48(1):5-12. PubMed ID: 9522024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of bromazepam in man after single administration of an oral solution.
    Ascalone V; Cisternino M; Sicolo N; De Palo E
    Arzneimittelforschung; 1984; 34(1):96-8. PubMed ID: 6142717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of (+)-catechin on the pharmacokinetics of carbamazepine in rabbits].
    Siegers CP; Pentz R; Younes M
    Arzneimittelforschung; 1982; 32(11):1440-2. PubMed ID: 6891250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of enteral tramadol formulations. 1st communication: capsules.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1986 Aug; 36(8):1278-83. PubMed ID: 3778568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
    Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of sucralfate on prednisone bioavailability.
    Gambertoglio JG; Romac DR; Yong CL; Birnbaum J; Lizak P; Amend WJ
    Am J Gastroenterol; 1987 Jan; 82(1):42-5. PubMed ID: 3799579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of valproic acid obtained after administration of three oral formulations to humans.
    Bialer M; Hussein Z; Dubrovsky J; Raz I; Abramsky O
    Isr J Med Sci; 1984 Jan; 20(1):46-9. PubMed ID: 6421770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.